Dr. Ramalingam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3404 Wake Forest Road
Raleigh, NC 27609
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2013 - 2016- Duke University HospitalResidency, Internal Medicine, 2010 - 2013
University of North Carolina at Chapel Hill School of MedicineClass of 2010
Certifications & Licensure
NC State Medical License 2010 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Development of a Cabozantinib (Cabometyx) Symptom Management Application for Use in Patients With Renal Cancer Start of enrollment: 2019 Aug 21
Publications & Presentations
PubMed
- Growing my practice, keeping up with medical knowledge, and handling adverse outcomes.Sundhar Ramalingam
Clinical Advances in Hematology & Oncology. 2018-11-01 - 25 citationsProstate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer.Sundhar Ramalingam, Michael S. Humeniuk, Rachel Hu, Julia Rasmussen, Patrick Healy
Urologic Oncology. 2017-01-23 - Novel Androgen Receptor Signaling Inhibitors for Nonmetastatic Castration-Resistant Prostate Cancer: The Light at the End of the Tunnel-or an Oncoming Train?Michael R. Harrison, Sundhar Ramalingam
Oncology. 2016-04-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
